Skip to main content

WCG to Lead Educational Session on Implementing the Revised Common Rule at AAHRPP Annual Conference

Princeton, NJ – May 20, 2019 – The WIRB-Copernicus Group® (WCG™) announced today that David Borasky, MPH, CIP, its vice president, IRB Compliance will be leading an educational session on the revised Common Rule at the Association for the Accreditation of Human Research Protection Programs, Inc. (AAHRPP) 2019 Annual Conference. This meeting will be held from May 21-23 at The Ritz Carlton New Orleans.

“WCG is delighted to continue to partner with AAHRPP on our shared mission of helping to ensure the highest standards of human subject protections in clinical trials,” said Mr. Borasky. “This conference will provide an excellent opportunity to share our experiences and best practices from implementing the revised Common Rule with our industry colleagues.”

Mr. Borasky will co-present “Institutional Policies, Process and Best Practices for Implementing the Key Information Requirement in the Revised Common Rule” during the inaugural Collaborative AAHRPP Network (CAN) pre-conference workshop. His fellow presenter will be Megan Kasamatis Singleton, JD, MBE, CIP, assistant dean, Human Research Protections and Director of the Human Research Protections Program at Johns Hopkins University School of Medicine.

Their session will provide an overview of the “key information” that now needs to be included in the consent materials for all research that is subject to the Common Rule. Mr. Borasky will outline The Secretary’s Advisory Committee on Human Research Protections (SACHRP) recommendations concerning this new regulatory requirement and also describe approaches taken by different organizations to address it. Mr. Borasky and Ms. Singleton will also facilitate an attendee discussion about how they are implementing this aspect of the rule, any issues they have experienced with it, and how AAHRPP can best address it through the organization’s tip sheets and processes.

Continuing WCG’s efforts to impart practical information to conference attendees, the company is also providing complimentary copies of its human research protection program standard operating procedures (SOPs) for AAHRPP Sections C and D at its booth. These documents were prepared by Jeffrey A. Cooper, MD, MMM, vice president, Process & Strategic Improvement at WCG and a co-founder of AAHRPP.

Also featured at the WCG booth will be the company’s “synchronous negotiation” solution that reduces or eliminates delays typically encountered when drafting the IRB-approved informed consent form during sponsor negotiations.

Further information about the AAHRPP Annual Conference is available at

About WCG

WCG is a global leader of solutions that measurably improve and accelerate clinical research. Biopharmaceutical and medical device companies, contract research organizations (CROs), research institutions, and sites partner with us for our unmatched expertise, data intelligence, and purpose-built technology to make informed decisions and optimize study outcomes, while maintaining the highest standards of human participant protection. WCG raises the bar by pioneering new concepts, reimagining processes, fostering compliance and safety, and empowering those who perform clinical trials to accelerate the delivery of medical therapies and devices that improve lives. For more information, please visit or follow us on LinkedIn or Twitter @WCGClinical.